These medications can be easily found online (if not pushed by advertisements) and available through compounding businesses, where I suspect screening for misuse does not occur
In one study, patients regained about two-thirds of the weight they had lost just one year after stopping semaglutide treatment, and their cardiometabolic risk markers (blood sugar, cholesterol, etc.) reverted toward baseline (source)
59 In MASLD patients with inadequate glycemic control on metformin, sitagliptin (a DPP-4 inhibitor) and liraglutide 1.8 mg daily showed no significant differences in improving LFC assessed by MRI-PDFF, visceral adipose tissue, and weight reduction
Normally glucagon is known for increasing blood glucose, but when carefully balanced alongside GLP-1 and GIP stimulation it may also: increase energy expenditure stimulate fat metabolism increase calorie burning improve liver fat reduction promote greater weight loss Essentially, GLP-1 and GIP reduce calorie intake whilst glucagon may increase calorie expenditure